NYRADA INC. (ASX:NYR) 58 Unlisted securities • 4,000,000 ESOP Options, with a term of 5 years and exercise price to be determined1 • 5,000,000 ESOP Options, with a term of 5 years and exercise price to be determined1 • 5,000,000 ESOP Options, with a term of 5 years and exercise price to be determined1 • 900,000 ESOP Options, with a term of 3 years and exercise price to be determined2 • 1,200,000 ESOP Options, with a term of 3 years and exercise price to be determined2 • 600,000 ESOP Options, with an expiry date of 18 January 2027 and exercise price to be determined2 • 600,000 ESOP Options, with an expiry date of 3 October 2029 and exercise price to be determined2 • 3,333,332 Broker Options, with an exercise price of $0.135 and expiry date of 30 June 2027 • 2,300,000 Broker Options, with an exercise price of $0.20 and expiry date of 31 December 2027 • 1,000,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2031 • 1,000,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 July 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 August 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 September 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 October 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 November 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 December 2032 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 January 2033 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 February 2033 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 March 2033 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 April 2033 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 May 2033 • 100,000 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2033 • 640,625 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2031 • 781,250 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 July 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 August 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 September 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 October 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 November 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 December 2032 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 January 2033 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 February 2033 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 March 2033 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 April 2033 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 May 2033 • 78,125 ESOP Options, with an exercise price of $0.19 and expiry date of 11 June 2033 • 6,944,000 Broker Options, with an exercise price of $0.45 and expiry date of 22 August 2027 • 3,000,000 Director Options, with an exercise price of $0.80 and expiry date of 12 November 2029 • 3,600,000 Director Options, with an exercise price of $0.80 and expiry date of 12 November 2030 • 3,600,000 Director Options, with an exercise price of $0.80 and expiry date of 12 November 2031 Note 1 - The exercise price is higher of: • 100% of the Fair Market Value (as defined in the Company's Stock Incentive Plan) of the Shares on the date that Option is granted; and • An amount equal to 110% of the volume weighted average price of the CDIs for the period of 10 trading days immediately prior to the date on which that Option vests. • An exercise price of $0.22 was used for the purpose of the fair value calculation at grant date. Note 2 - The exercise price is higher of: • 100% of the Fair Market Value (as defined in the Company's Stock Incentive Plan) of the Shares on the date that Option is granted; and • An amount equal to 120% of the volume-weighted average price of the CDIs for the period of 10 trading days immediately prior to the date on which the Option vests. • An exercise price of $0.24 was used for the purpose of the fair value calculation at grant date.
RkJQdWJsaXNoZXIy MjE2NDg3